BENEFIT PLANS - Shares Outstanding (Details) - $ / shares shares in Thousands |
6 Months Ended | 12 Months Ended |
|---|---|---|
Jun. 30, 2026 |
Dec. 31, 2025 |
|
| Restricted Stock | ||
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||
| Outstanding (shares) | 382 | 245 |
| Weighted average grant date fair value (in dollars per share) | $ 13.42 | $ 13.41 |
| Unvested Restricted Stock | ||
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||
| Outstanding (shares) | 24 | 31 |
| X | ||||||||||
- Definition The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|